Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twelve and twenty-four months
Awards & highlights
Study Summary
This trial compared lumbar fusion rates at 12 and 24 months after surgery using Virtuous or Autograft Bone Graft.
Who is the study for?
This trial is for adults over 18 with Degenerative Disc Disease (DDD) needing lumbar spine fusion surgery at 1-2 levels. They must have tried conservative care for 6+ months without relief, and can't be pregnant or planning pregnancy within two years post-surgery. Prior lumbar fusion or treatment for malignancy in the last five years disqualifies them.Check my eligibility
What is being tested?
The study compares the effectiveness of a bone graft material called Virtuos against traditional Autograft Bone Graft in lumbar spine fusion surgeries after 12 and 24 months. The surgical approach includes TLIF with posterior fixation, following FDA guidelines.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks may include pain at the graft site, infection, nerve damage, blood clots, graft rejection or failure to fuse properly which might necessitate additional surgeries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ twelve months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twelve months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Successful Fusion
Secondary outcome measures
Clinical Outcomes
Safety Profile
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VirtuousExperimental Treatment1 Intervention
Virtuous +/- Local Bone
Group II: AutograftActive Control1 Intervention
Autograft +/- Allograft Chips
Find a Location
Who is running the clinical trial?
Orthofix Inc.Lead Sponsor
15 Previous Clinical Trials
6,302 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need a specific spine surgery involving 1-2 backbones.I can attend all follow-up visits and follow the study plan.I am currently receiving treatment for cancer or have recently.I have a mild case of a slipped vertebra.I am having lumbar spine fusion surgery with a specific type of bone graft.I am younger than 18 years old.I am 18 years old or older.I am currently fighting an infection or being treated for one.I have had spine fusion surgery in my lower back.My condition hasn't improved with standard treatments for over 6 months.My lower back has a significant slip between the bones.My diagnosis of DDD is confirmed with specific imaging results.
Research Study Groups:
This trial has the following groups:- Group 1: Virtuous
- Group 2: Autograft
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this medical study still available to individuals?
"According to public record, this clinical trial is still actively seeking participants. It was first made available on the 3rd of January 2023 and had its last update on November 10th 2022."
Answered by AI
What is the total number of individuals participating in this clinical experiment?
"Affirmative. Clinicaltrials.gov states that the trial, which was first advertised on March 1st 2023, is still actively recruiting patients. 75 participants are required from a single medical centre for this study to be completed successfully."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger